3rd Ophthalmic Drug Delivery Summit

  • 28-30 Jan 2025
  • The Clift Royal Sonesta San Francisco, CA, United States

Description

The 3rd Ophthalmic Drug Delivery Summit addresses innovations in ophthalmic drug delivery methods and devices, focusing on achieving minimally invasive, sustained-release solutions for treating eye diseases.

Topics
  • Suprachoroidal Delivery in Gene Therapy to Capitalize on Ocular Anatomy
  • Overcoming Hurdles in Ophthalmic Clinical Trial Design to Spearhead Development
  • The State of Play for Ophthalmic Drug Delivery to the Retina
  • Advancing Retinal Therapy With Sustained Release Implants to Reduce Treatment Frequency
  • The Journey of Genentech’s Susvimo Port Delivery System’s from Challenges to FDA Reapproval
  • Advancements in Large Volume Formulations & High Viscosity Injectable Drug Delivery
  • Drug Delivery Mechanics for Extended Release Implants
  • Establishing Robust Clinical Trial Design to Overcome Past Failings
  • Overcoming Inflammatory Responses to Maximize Therapeutic Effect
  • The Evolving Landscape of Regulatory Approvals for Combination Products
  • Navigating the Safety Landscape of Novel Drug Delivery
  • Advancing Drug Formulations & Combinations to Achieve Sustained Release
  • Advancing Targeted, Compartmentalized & Long-Acting Depot Delivery: Synergistic Combination of Particulate Formulation & Suprachoroidal Route of Administration
  • Enhancing Ocular Drug Delivery Through Combined Microparticles, Nanoparticles & Hydrogels
  • Mastering Suprachoroidal Delivery to Increase Distribution & Durability
  • Expanding the Potential of the Suprachoroidal Space in Retinal Therapy
  • Considering Non-Invasive Administration of Medications for Retinal Diseases : a Mechanism of Action Perspective
  • Comparing of Existing Ophthalmic Models Approaches to Supercharge Development
  • Utilizing Preclinical & Computational Models for Predicting Human Ophthalmic Drug Behavior
  • Delivery Effective Cell & Gene Therapies to the Eye to Halt Vision Loss
  • Optimizing Current Suprachoroidal & Subretinal Delivery of AAV Gene Therapies
  • Enhancing Cell & Gene Therapies With Advanced Hydrogel Platforms
  • Disease Indication & Endpoint Selection for Ophthalmic Gene Therapy Trials to Unlock Optimal Results
  • Innovations with Topical & Oral Medications & the Path to Regulatory Success
  • Considering Systemic Administration of PPARalpha Agonist for the Treatment of Diabetic Retinopathy & AMD

Venue

  • The Clift Royal Sonesta San Francisco , 495 Geary St, San Francisco, California, United States

More Details

Prices:
2599-5097 US Dollar (Estimated)
Exhibition:
No exhibition
Organizer:
Hanson Wade
Website:

Future Events

Important

Please, check "Ophthalmic Drug Delivery Summit" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Ophthalmology, Pharma

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions